GlaxoSmithKline Pharmaceuticals (NSE:GLAXO) Net Income (Continuing Operations) : ₹9,276 Mil (TTM As of Mar. 2025)

View and export this data going back to 2000. Start your Free Trial

What is GlaxoSmithKline Pharmaceuticals Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. GlaxoSmithKline Pharmaceuticals's Net Income (Continuing Operations) for the three months ended in Mar. 2025 was ₹2,629 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Mar. 2025 was ₹9,276 Mil.

GlaxoSmithKline Pharmaceuticals Net Income (Continuing Operations) Historical Data

The historical data trend for GlaxoSmithKline Pharmaceuticals's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GlaxoSmithKline Pharmaceuticals Net Income (Continuing Operations) Chart

GlaxoSmithKline Pharmaceuticals Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Net Income (Continuing Operations)

Get a 7-Day Free Trial

2,872.69

3,807.69

6,076.42

5,899.60

9,275.80

GlaxoSmithKline Pharmaceuticals Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Net Income (Continuing Operations)	Get a 7-Day Free Trial															1,944.80	1,823.30	2,525.00	2,298.80	2,628.70

GlaxoSmithKline Pharmaceuticals Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹9,276 Mil.

GlaxoSmithKline Pharmaceuticals (NSE:GLAXO) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

GlaxoSmithKline Pharmaceuticals Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of GlaxoSmithKline Pharmaceuticals's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.

GlaxoSmithKline Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GlaxoSmithKline Pharmaceuticals Ltd (NSE:GLAXO) » Definitions » Net Income (Continuing Operations)

Comparable Companies

Traded in Other Exchanges

500660:India

Address

Dr. Annie Besant Road, GSK House, Worli, Mumbai, MH, IND, 400030

Website

https://www.gsk-india.com

GlaxoSmithKline Pharmaceuticals Ltd is an India-based subsidiary of GlaxoSmithKline plc. GSK India develops and manufactures medicines, vaccines, and consumer products. Its medicines portfolio includes prescription drugs for conditions that include asthma, infectious diseases, mental health, and digestion, as well as nonprescription nutrition and cosmetic products. Its vaccines product line includes treatments for conditions such as influenza, HPV, hepatitis, and measles. Its consumer healthcare products include Horlicks-brand packaged food and beverage powders among other retail products. The company derives majority of its revenue from India.

GlaxoSmithKline Pharmaceuticals Headlines

No Headlines